期刊文献+

吴茱萸碱与吴茱萸次碱经PXR、CAR核受体通路影响CYP3A4表达的研究 被引量:11

Effects of Evodiamine and Rutecarpine on Human CYP 3A4 through PXR and CAR Pathway
原文传递
导出
摘要 目的:研究吴茱萸碱与吴茱萸次碱能否通过孕烷X受体(PXR)、组成型雄甾烷受体(CAR)通路转录调节CYP3A4的活性。方法:PXR表达质粒与CYP3A4报告质粒、CAR表达质粒与CYP3A4报告质粒瞬时转染到LS174T细胞后,分别给予2.5、10、40μmol/L浓度的吴茱萸碱与吴茱萸次碱,采用报告基因检测CYP3A4荧光素酶活性;采用二步灌流法分离小鼠原代肝细胞,给予2.5、10、40μmol/L浓度的吴茱萸碱与吴茱萸次碱,采用实时荧光定量链式聚合酶反应(R-PCR)与液相色谱-串联质谱(LC-MS/MS)法检测小鼠原代肝细胞中CYP3A11基因表达和酶活性。结果:在10、40μmol/L浓度下,吴茱萸碱经PXR核受体通路使CYP3A4报告基因荧光素酶活性分别增加至3.41、4.15倍;10、40μmol/L浓度下吴茱萸次碱能使利福平对PXR的诱导作用减少,分别降低37.7%、45.34%,吴茱萸次碱能使CAR阳性药物CITCO对CAR的诱导作用减少29%。10、40μmol/L浓度下吴茱萸碱能使CYP3A11 mRNA表达分别增加至2.67、3.80倍;40μmol/L浓度下吴茱萸次碱能下调原代小鼠肝细胞中35%的CYP3A11 mRNA表达。10、40μmol/L浓度下吴茱萸碱能显著增加CYP3A11酶功能活性分别至3.63、3.01倍;吴茱萸次碱在40μmol/L浓度下能显著减少34.54%CYP3A11酶功能活性。结论:吴茱萸碱能通过PXR核受体通路诱导CYP3A4荧光素酶、mRNA表达及酶活性,吴茱萸次碱能通过PXR、CAR通路共同抑制CYP3A4荧光素酶、mRNA表达及酶活性。 OBJECTIVE:To study the effects of evodiamine and rutecarpine on the activity of cytochrome CYP 3A4 through pregnane X receptor(PXR)and constitutive androstane receptor(CAR)pathway.METHODS:PXR plasmid and the CYP3A4 report plasmid or CAR plasmid and the CYP3A4 report plasmid were transiently transfected into the LS174T cell,and the evodiamine and rutecarpine 2.5,10 and 40 μmol/L were incubated with the LS174T cell.The activities of luciferase were determined with CYP3A4 report gene.Primary hepatocytes were isolated from mice by two steps perfusion method and then treated with evodiamine and rutecarpine 2.5,10 and 40 μ mol/L.CYP3A11 mRNA expression and enzymatic activity of primary hepatocytes were measured using real-time PCR and LC-MS/MS.RESULTS:The evodiamine 10 and 40 μmol/L could significantly enhanced 3.41 and 4.15 folds of luciferase activity in CYP3A4 report gene through PXR pathway.Rutecarpine 10 and 40 μmol/L could reduce the effect of rifampicin on PXR,decreasing by 37.7% and 45.34%,respectively.Rutecarpine could reduce 29% induction of CAR caused by CITCO(positive activator of CAR).After exposed to evodiamine 10,40 μmol/L,the expression of CYP3A11 mRNA was significantly 2.67 and 3.80 fold increased,respectively;the expressions of CYP3A11 mRNA in 35% primary hepatocytes were significantly down-regulated by rutecarpine 40 μmol/L.Evodiamine 10,40 μmol/L increased 3.63 and 3.01 folds of CYP3A11 enzyme activity significantly;after exposed to rutecarpine 40 μmol/L,CYP3A4 enzyme activity was decreased by 34.54% significantly.CONCLUSIONS:Evodiamine can significantly enhance the CYP3A4 luciferase,mRNA expression and enzyme activity through PXR mediated pathway.Rutecarpine can significantly inhibit the CYP3A4 luciferase,RNA expression and enzyme activity through PXR/CAR mediated pathway.
出处 《中国药房》 CAS CSCD 2013年第35期3274-3279,共6页 China Pharmacy
关键词 吴茱萸碱 吴茱萸次碱 药物相互作用 孕烷X受体 组成型雄甾烷受体 CYP3A4 Evodiamine Rutecarpine Drug interaction Pregnane X receptor Constitutive androstane receptor CYP3A4
  • 相关文献

参考文献14

  • 1Fugh-Berman A. Herb-drug interactions[J]. Lancet, 2000, 355(9 198) : 134.
  • 2Shimada T, Yamazaki H, Mimura M, et al. Interindividu- al variations in human liver cytochrome P450 enzymes in- volved in the oxidation of drugs, carcinogens and toxic chemicals [J]. J Pharmaeol Exp Ther, 1994,270 ( 1 ) : 414.
  • 3谷元,司端运,刘昌孝.CYP3A4酶介导的人类药物代谢性别差异[J].中国药理学通报,2009,25(9):1121-1124. 被引量:19
  • 4Moore LB, Maglich JM, McKee DD, et al. Pregnane X receptor (PXR), constitutive androstane receptor (CAR) and benzoate X receptor (BXR) define three pharmaco- logically distinct classes of nuclear receptors[J]. Mol En- docrinol, 2002,16 ( 5 ) : 977.
  • 5Chu V, Einolf HJ, Evers R, et al. In vitro an- d in vivo induction of cytochrome P450: a survey of the current practices and recommendations: a pharmaceutical re- search and manufacturers of america perspective[J]. Drug Metab Dispos, 2009,37 (7) : 1 339.
  • 6谢宗万.全国中草药汇编:上册[M].北京:人民卫生出版社,1975.212.
  • 7唐元清,冯孝章,黄量.吴茱萸化学成分的研究[J].药学学报,1996,31(2):151-155. 被引量:67
  • 8戴媛媛,刘保林,窦昌贵.吴茱萸及其有效成分的药理研究进展[J].中药材,2003,26(4):295-298. 被引量:29
  • 9Burk O, Amold KA, Geick A, et al. A role for constitu- tive androstane receptor in the regulation of human intesti- nal MDR 1 expression[J]. Biol Chem, 2005,386(6) :503.
  • 10Goodwin B, Liddle E, Hodgsonand C. The orphan hu- man pregnane X receptor mediates the transcriptional acti- vation of CYP3A4 by rifampicin through a distal enhanc- er module[J]. MolPharmacol, 1999, 56(6) : 1 329.

二级参考文献77

  • 1王锐,倪京满,马星.中药吴茱萸挥发油成分的研究[J].中国药学杂志,1993,28(1):16-18. 被引量:27
  • 2唐元清,冯孝章,黄量.吴茱萸化学成分的研究[J].药学学报,1996,31(2):151-155. 被引量:67
  • 3汪赛赢,周宏灏.肠道组织中维生素D受体作用的研究进展[J].中国药理学通报,2007,23(2):151-154. 被引量:6
  • 4张松波,周宏灏.药物代谢性别差异及与核受体的关系[J].中国药理学通报,2007,23(3):292-294. 被引量:23
  • 5刘蕴秀 等.吴茱萸中生物碱成分的研究新进展[J].天然产物研究与开发,1999,12(1):87-87.
  • 6Anderson G D. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics,pharmacokinetics, and pharmacodynamics [ J ]. J Womens Health ( Larchmt ), 2005,14 ( 1 ) : 19 - 29.
  • 7Liu Y T,Hao H P,Liu C X,et al. Drugs as CYP3A probes,inducers,and inhibitors[ J]. Drug Metab Rev, 2007,39(4) :699 -721.
  • 8Michalets E L. Update:clinically significant cytochrome P-450 drug interactions [ J ]. Pharmacotherapy, 1998,18 ( 1 ) : 84 - 112.
  • 9Dadashzadeh S, Javadian B, Sadeghian S. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human [ J]. Biopharm Drug Dispos ,2006,27 ( 7 ) :329 - 34.
  • 10Cummins C L, Wu C Y, Benet L Z. Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by Pglycoprotein[ J]. Clin Pharmacol Ther,2002,72 ( 5 ) :474 - 89.

共引文献110

同被引文献174

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部